Antares Pharma, Inc. (NASDAQ:ATRS)

CAPS Rating: 3 out of 5

The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral fast melting tablets and reusable needle-free and disposable mini-needle injector systems.

Recs

0
Player Avatar dmsrz8 (61.56) Submitted: 7/12/2012 7:42:36 PM : Outperform Start Price: $3.81 ATRS Score: -8.19

I really feel like this is a company worth while to everyone in times of uncertainty. Though there is some volatility associated with the company related to the overall health of the market, with a balance sheet that has NO debt, and several items in development and out already, not to mention a recent partnership with Pfiser, this company really seems like it is an absolute STEAL right now below $5 a share. Will only go up.

Featured Broker Partners


Advertisement